Molina tumbles despite Q2 beat amid high medical expenses
Seeking Alpha News (Thu, 23-Jul 10:27 AM ET)
Oscar Health, Inc. 2026 Second Quarter Earnings Conference Call
Business Wire (Mon, 13-Jul 8:00 AM ET)
Oscar Health's First Quarter 2026 Results Reveal Substantial Earnings Growth and Margin Expansion
Market Chameleon (Wed, 6-May 3:08 AM ET)
Oscar Health Announces Strong Financial Results for First Quarter 2026 And Reaffirms 2026 Guidance
Business Wire (Wed, 6-May 6:00 AM ET)
Oscar Health Gains Experienced Board Leadership with Bill Gassen’s Appointment
Market Chameleon (Mon, 30-Mar 4:56 AM ET)
Oscar Health Sets Record Membership and Projects Return to Profitability in 2026
Market Chameleon (Tue, 10-Feb 2:09 AM ET)
Oscar Health Inc is a healthcare technology company built around a full stack technology platform and a relentless focus on serving its members. It offers Individual & Family plans and health technology solutions that power the healthcare industry. Oscar operates as one segment to sell insurance to individuals, families and employees through the federal and state-run healthcare exchanges formed in conjunction with the Patient Protection and Affordable Care Act (ACA) and leverages its technology platform to provide services via its Oscar offering.
Oscar Health Class A trades on the NYSE stock market under the symbol OSCR.
As of July 23, 2026, OSCR stock price declined to $28.92 with 4,037,845 million shares trading.
OSCR has a beta of 2.80, meaning it tends to be more sensitive to market movements. OSCR has a correlation of 0.23 to the broad based SPY ETF.
OSCR has a market cap of $8.72 billion. This is considered a Mid Cap stock.
Last quarter Oscar Health Class A reported $5 billion in Revenue and $2.07 earnings per share. This fell short of revenue expectation by $-265 million and exceeded earnings estimates by $.95.
In the last 3 years, OSCR traded as high as $33.10 and as low as $4.72.
The top ETF exchange traded funds that OSCR belongs to (by Net Assets): VTI, AVUV, IWM, VB, VBK.
OSCR has outperformed the market in the last year with a return of +96.7%, while the SPY ETF gained +18.6%. In the last 3 month period, OSCR beat the market returning +75.9%, while SPY returned +4.1%. However, in the most recent 2 weeks OSCR has underperformed the stock market by returning -6.1%, while SPY returned -1.0%.
OSCR support price is $28.27 and resistance is $30.74 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OSCR shares will trade within this expected range on the day.